-
BTG INTERNATIONAL LIMITED et al v. GLENMARK PHARMACEUTICALS INC., USA et al DC
- 2:16-cv-03743
- D.N.J.
- Judge: Kevin McNulty
+1
- Filed: 06/24/2016
- Closed: 12/07/2017
- Latest Docket Entry: 12/07/2017
- PACER
- Docket updated daily
4
Plaintiffs
3
Defendants
1
Accused
Product
1
Patent-in-Suit
532
Days in
Litigation
-
BTG INTERNATIONAL LIMITED et al v. GLENMARK PHARMACEUTICALS INC., USA et al DC
- 2:16-cv-03743
- D.N.J.
- Judge: Kevin McNulty
+1
- Filed: 06/24/2016
- Closed: 12/07/2017
- Latest Docket Entry: 12/07/2017
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim | Outcome |
|---|---|
| All challenged claims |
Enforceable and Valid
Entry 37 |
-
Infringement
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 | All Asserted Claims |
Infringement
Entry 37
|
Glenmark Pharmaceuticals SA
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 | All Asserted Claims |
Infringement
Entry 37
|
